DiscoverAxial PodcastBiotech Company Building, Partnering, Investing Towards Better Medicines with Vikas Goyal
Biotech Company Building, Partnering, Investing Towards Better Medicines with Vikas Goyal

Biotech Company Building, Partnering, Investing Towards Better Medicines with Vikas Goyal

Update: 2023-07-09
Share

Description

Vikas Goyal has one of the best records in biotech having spent over 8 years at SR One partnering with companies like Nimbus and Morphic Therapeutic before joining Pandion Therapeutics (acquired by Merck) full-time after investing in it as well. Now starting Trekk Venture Parners, Vikas' story uniquely blends success across investing, operations, and company building.




Starting off his career at McKinsey, Vikas went on to work with dozens of start-ups and early-stage companies as a consultant at Extera Partners then went off to earn his MBA in healthcare management from Wharton. He started work in business development at Infinity Pharmaceuticals before joining SR One full-time after an internship there during business school.



Comments 
loading
In Channel
loading
00:00
00:00
1.0x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Biotech Company Building, Partnering, Investing Towards Better Medicines with Vikas Goyal

Biotech Company Building, Partnering, Investing Towards Better Medicines with Vikas Goyal

Joshua Elkington